The UK Parliament and EU Commission have now agreed on a wide-ranging EU-UK Trade and Cooperation Agreement, focused on the supply of goods. Pharmaceuticals are highlighted in a number of areas. For example, Annex TBT-2 of the Agreement provides for recognition of Good Manufacturing Practice (GMP) inspections for medicinal products carried out in the other party’s jurisdiction, i.e. across the UK and EU. In his most recent blog here, Adrian Spooner explains this and other new regulatory and intellectual property provisions.